Results
|
54201.
|
|
|
54202.
|
|
|
54203.
|
|
|
54204.
|
|
|
54205.
|
|
|
54206.
|
The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells. [electronic resource] by
- Tong, Wei-Gang
- Estrov, Zeev
- Wang, Yongtao
- O'Brien, Susan
- Faderl, Stefan
- Harris, David M
- Van Pham, Quin
- Hazan-Halevy, Inbal
- Liu, Zhiming
- Koch, Patricia
- Kantarjian, Hagop
- Keating, Michael J
- Ferrajoli, Alessandra
Producer: 20120123
In:
Investigational new drugs vol. 29
Availability: No items available.
|
|
54207.
|
|
|
54208.
|
|
|
54209.
|
|
|
54210.
|
|
|
54211.
|
|
|
54212.
|
Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium. [electronic resource] by
- Bradley, Deborah A
- Daignault, Stephanie
- Ryan, Charles J
- Dipaola, Robert S
- Cooney, Kathleen A
- Smith, David C
- Small, Eric
- Mathew, Paul
- Gross, Mitchell E
- Stein, Mark N
- Chen, Alice
- Pienta, Kenneth J
- Escara-Wilke, June
- Doyle, Gerald
- Al-Hawary, Mahmoud
- Keller, Evan T
- Hussain, Maha
Producer: 20120123
In:
Investigational new drugs vol. 29
Availability: No items available.
|
|
54213.
|
|
|
54214.
|
|
|
54215.
|
|
|
54216.
|
|
|
54217.
|
|
|
54218.
|
|
|
54219.
|
|
|
54220.
|
|